One and two-year clinical outcomes for a polyethylene glenoid with a fluted peg

one thousand two hundred seventy individual patients from eleven centers

Frederick A. Matsen, Joseph P. Iannotti, R. Sean Churchill, Lieven De Wilde, T. Bradley Edwards, Matthew C. Evans, Edward V. Fehringer, Gordon I. Groh, James D. Kelly, Christopher M. Kilian, Giovanni Merolla, Tom R. Norris, Giuseppe Porcellini, Edwin E. Spencer, Anne Vidil, Michael A Wirth, Stacy M. Russ, Moni Neradilek, Jeremy S. Somerson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Clinical shoulder science lacks a benchmark against which the early clinical value of new glenoid components can be compared; such a benchmark may be derived from a multicenter study of patients receiving an established, internationally used design of glenoid component. Methods: We obtained data from 11 centers on 1270 patients having total shoulder arthroplasty using an all-polyethylene component with a fluted central peg. We analyzed individual patient outcomes at 1 and 2 years after surgery. We compared the improvement for each patient to the minimal clinically important difference (MCID) and calculated each patient’s improvement as a percent of maximal possible improvement (MPI). Results: The preoperative scores improved from SST 3 ± 2, ASES 37 ± 15, Constant score 36 ± 16, and Penn score 30 ± 19 to SST 10 ± 2, ASES 90 ± 12, Constant 76 ± 13, and Penn 80 ± 24 (p < 0.001 for each). A high percentage of patients improved by more than the MCID (SST 96%, ASES 98%, Constant 94%, Penn 93%) and obtained improvement of at least 30% of the MPI (SST 95%, ASES 98%, Constant 91%, Penn 87%). The clinical outcomes realized with this glenoid design were not worse for the 41% of shoulders with preoperative type B glenoids or for the 30% of shoulders with more than 15 degrees of glenoid retroversion. Conclusions: Individual patients from 11 international practices having total shoulder arthroplasty using a basic glenoid component design obtained highly significant clinical outcomes, providing a benchmark against which the early outcomes of new designs can be compared to determine whether they provide increased clinical value.

Original languageEnglish (US)
JournalInternational Orthopaedics
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Polyethylene
Benchmarking
Arthroplasty
Multicenter Studies

Keywords

  • All-polyethylene
  • Clinical outcomes
  • Glenoid
  • Ingrowth
  • Minimal clinically important difference
  • Peg
  • Percentage of maximal possible improvement

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

One and two-year clinical outcomes for a polyethylene glenoid with a fluted peg : one thousand two hundred seventy individual patients from eleven centers. / Matsen, Frederick A.; Iannotti, Joseph P.; Churchill, R. Sean; De Wilde, Lieven; Edwards, T. Bradley; Evans, Matthew C.; Fehringer, Edward V.; Groh, Gordon I.; Kelly, James D.; Kilian, Christopher M.; Merolla, Giovanni; Norris, Tom R.; Porcellini, Giuseppe; Spencer, Edwin E.; Vidil, Anne; Wirth, Michael A; Russ, Stacy M.; Neradilek, Moni; Somerson, Jeremy S.

In: International Orthopaedics, 01.01.2018.

Research output: Contribution to journalArticle

Matsen, FA, Iannotti, JP, Churchill, RS, De Wilde, L, Edwards, TB, Evans, MC, Fehringer, EV, Groh, GI, Kelly, JD, Kilian, CM, Merolla, G, Norris, TR, Porcellini, G, Spencer, EE, Vidil, A, Wirth, MA, Russ, SM, Neradilek, M & Somerson, JS 2018, 'One and two-year clinical outcomes for a polyethylene glenoid with a fluted peg: one thousand two hundred seventy individual patients from eleven centers', International Orthopaedics. https://doi.org/10.1007/s00264-018-4213-3
Matsen, Frederick A. ; Iannotti, Joseph P. ; Churchill, R. Sean ; De Wilde, Lieven ; Edwards, T. Bradley ; Evans, Matthew C. ; Fehringer, Edward V. ; Groh, Gordon I. ; Kelly, James D. ; Kilian, Christopher M. ; Merolla, Giovanni ; Norris, Tom R. ; Porcellini, Giuseppe ; Spencer, Edwin E. ; Vidil, Anne ; Wirth, Michael A ; Russ, Stacy M. ; Neradilek, Moni ; Somerson, Jeremy S. / One and two-year clinical outcomes for a polyethylene glenoid with a fluted peg : one thousand two hundred seventy individual patients from eleven centers. In: International Orthopaedics. 2018.
@article{365906030c3e4b28be76f40dc6fefba3,
title = "One and two-year clinical outcomes for a polyethylene glenoid with a fluted peg: one thousand two hundred seventy individual patients from eleven centers",
abstract = "Purpose: Clinical shoulder science lacks a benchmark against which the early clinical value of new glenoid components can be compared; such a benchmark may be derived from a multicenter study of patients receiving an established, internationally used design of glenoid component. Methods: We obtained data from 11 centers on 1270 patients having total shoulder arthroplasty using an all-polyethylene component with a fluted central peg. We analyzed individual patient outcomes at 1 and 2 years after surgery. We compared the improvement for each patient to the minimal clinically important difference (MCID) and calculated each patient’s improvement as a percent of maximal possible improvement (MPI). Results: The preoperative scores improved from SST 3 ± 2, ASES 37 ± 15, Constant score 36 ± 16, and Penn score 30 ± 19 to SST 10 ± 2, ASES 90 ± 12, Constant 76 ± 13, and Penn 80 ± 24 (p < 0.001 for each). A high percentage of patients improved by more than the MCID (SST 96{\%}, ASES 98{\%}, Constant 94{\%}, Penn 93{\%}) and obtained improvement of at least 30{\%} of the MPI (SST 95{\%}, ASES 98{\%}, Constant 91{\%}, Penn 87{\%}). The clinical outcomes realized with this glenoid design were not worse for the 41{\%} of shoulders with preoperative type B glenoids or for the 30{\%} of shoulders with more than 15 degrees of glenoid retroversion. Conclusions: Individual patients from 11 international practices having total shoulder arthroplasty using a basic glenoid component design obtained highly significant clinical outcomes, providing a benchmark against which the early outcomes of new designs can be compared to determine whether they provide increased clinical value.",
keywords = "All-polyethylene, Clinical outcomes, Glenoid, Ingrowth, Minimal clinically important difference, Peg, Percentage of maximal possible improvement",
author = "Matsen, {Frederick A.} and Iannotti, {Joseph P.} and Churchill, {R. Sean} and {De Wilde}, Lieven and Edwards, {T. Bradley} and Evans, {Matthew C.} and Fehringer, {Edward V.} and Groh, {Gordon I.} and Kelly, {James D.} and Kilian, {Christopher M.} and Giovanni Merolla and Norris, {Tom R.} and Giuseppe Porcellini and Spencer, {Edwin E.} and Anne Vidil and Wirth, {Michael A} and Russ, {Stacy M.} and Moni Neradilek and Somerson, {Jeremy S.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s00264-018-4213-3",
language = "English (US)",
journal = "International Orthopaedics",
issn = "0341-2695",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - One and two-year clinical outcomes for a polyethylene glenoid with a fluted peg

T2 - one thousand two hundred seventy individual patients from eleven centers

AU - Matsen, Frederick A.

AU - Iannotti, Joseph P.

AU - Churchill, R. Sean

AU - De Wilde, Lieven

AU - Edwards, T. Bradley

AU - Evans, Matthew C.

AU - Fehringer, Edward V.

AU - Groh, Gordon I.

AU - Kelly, James D.

AU - Kilian, Christopher M.

AU - Merolla, Giovanni

AU - Norris, Tom R.

AU - Porcellini, Giuseppe

AU - Spencer, Edwin E.

AU - Vidil, Anne

AU - Wirth, Michael A

AU - Russ, Stacy M.

AU - Neradilek, Moni

AU - Somerson, Jeremy S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: Clinical shoulder science lacks a benchmark against which the early clinical value of new glenoid components can be compared; such a benchmark may be derived from a multicenter study of patients receiving an established, internationally used design of glenoid component. Methods: We obtained data from 11 centers on 1270 patients having total shoulder arthroplasty using an all-polyethylene component with a fluted central peg. We analyzed individual patient outcomes at 1 and 2 years after surgery. We compared the improvement for each patient to the minimal clinically important difference (MCID) and calculated each patient’s improvement as a percent of maximal possible improvement (MPI). Results: The preoperative scores improved from SST 3 ± 2, ASES 37 ± 15, Constant score 36 ± 16, and Penn score 30 ± 19 to SST 10 ± 2, ASES 90 ± 12, Constant 76 ± 13, and Penn 80 ± 24 (p < 0.001 for each). A high percentage of patients improved by more than the MCID (SST 96%, ASES 98%, Constant 94%, Penn 93%) and obtained improvement of at least 30% of the MPI (SST 95%, ASES 98%, Constant 91%, Penn 87%). The clinical outcomes realized with this glenoid design were not worse for the 41% of shoulders with preoperative type B glenoids or for the 30% of shoulders with more than 15 degrees of glenoid retroversion. Conclusions: Individual patients from 11 international practices having total shoulder arthroplasty using a basic glenoid component design obtained highly significant clinical outcomes, providing a benchmark against which the early outcomes of new designs can be compared to determine whether they provide increased clinical value.

AB - Purpose: Clinical shoulder science lacks a benchmark against which the early clinical value of new glenoid components can be compared; such a benchmark may be derived from a multicenter study of patients receiving an established, internationally used design of glenoid component. Methods: We obtained data from 11 centers on 1270 patients having total shoulder arthroplasty using an all-polyethylene component with a fluted central peg. We analyzed individual patient outcomes at 1 and 2 years after surgery. We compared the improvement for each patient to the minimal clinically important difference (MCID) and calculated each patient’s improvement as a percent of maximal possible improvement (MPI). Results: The preoperative scores improved from SST 3 ± 2, ASES 37 ± 15, Constant score 36 ± 16, and Penn score 30 ± 19 to SST 10 ± 2, ASES 90 ± 12, Constant 76 ± 13, and Penn 80 ± 24 (p < 0.001 for each). A high percentage of patients improved by more than the MCID (SST 96%, ASES 98%, Constant 94%, Penn 93%) and obtained improvement of at least 30% of the MPI (SST 95%, ASES 98%, Constant 91%, Penn 87%). The clinical outcomes realized with this glenoid design were not worse for the 41% of shoulders with preoperative type B glenoids or for the 30% of shoulders with more than 15 degrees of glenoid retroversion. Conclusions: Individual patients from 11 international practices having total shoulder arthroplasty using a basic glenoid component design obtained highly significant clinical outcomes, providing a benchmark against which the early outcomes of new designs can be compared to determine whether they provide increased clinical value.

KW - All-polyethylene

KW - Clinical outcomes

KW - Glenoid

KW - Ingrowth

KW - Minimal clinically important difference

KW - Peg

KW - Percentage of maximal possible improvement

UR - http://www.scopus.com/inward/record.url?scp=85058020861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058020861&partnerID=8YFLogxK

U2 - 10.1007/s00264-018-4213-3

DO - 10.1007/s00264-018-4213-3

M3 - Article

JO - International Orthopaedics

JF - International Orthopaedics

SN - 0341-2695

ER -